Kiadis abandons lead PhIII program, shifts focus to natural killer cells
12 Nov 2019 //
ENDPTS
Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.
05 Jun 2019 //
BIOSPACE
Stem cell transplant firms Kiadis and CytoSen join forces
18 Apr 2019 //
ENDPTS
Kiadis to buy CytoSen, adding June to advisory board
17 Apr 2019 //
FIERCE BIOTECH
CytoSen Receives FDA’s Response to Pre-IND Meeting for Ph 2 Study in AML
27 Sep 2018 //
BUSINESSWIRE
CytoSen Thera`s Receives FDA’s Favorable Response to Pre-IND Meeting for AML
27 Sep 2018 //
BUSINESSWIRE